ArticleBritish journal of cancer2012

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma.

R B Erlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.